Myovant’s uterine fibroid drug worked in Phase 3. Now comes competition

Myovant’s uterine fibroid drug worked in Phase 3. Now comes competition

STAT Plus: Myovant’s uterine fibroid drug worked in Phase 3. Now comes competition

By DAMIAN GARDE

ADOBE

Myovant Sciences said its treatment for uterine fibroids succeeded in the first of two large trials, a major step toward winning approval.

READ MORE